I told people this was undervalued. I said that biotech stocks that target orphan diseases tend to go up higher than other biotech stocks. Aplastic anemia is an unmet medical need where the patient fails to produce enough red blood cells in the bone marrow. Hemaxellerate could be huge!
Also don't forget about the IND coming soon on the MIN technology for the breast cancer vaccine!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.